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Abstract
Background: Anamika et al[1] recently published in this journal a sequence alignment analysis of protein kinases
encoded by the chimpanzee genome in comparison to those in the human genome. From this analysis they
concluded that several chimpanzee kinases have unusual domain arrangements.
Results: Re-examination of these kinases reveals claimed novel arrangements cannot withstand scrutiny; each is
either not novel or represents over-analysis of weakly confident computer generated gene models. Additional
sequence evidence available at the time of the paper’s submission either directly contradict the gene models or
suggest alternate gene models. These alternate models would minimize or eliminate the observed differences
between human and chimp kinases.
Conclusion: None of the proposed novel chimpanzee kinase architectures are supported by experiment evidence.
Guidelines to prevent such erroneous conclusions in similar papers are proposed.
Background
In a recent paper in this journal, Anamika et al present
an analysis comparing the sets of protein kinases
encoded in the human and chimpanzee genome. Based
on this, they concluded that chimps possess many
kinases with unprecedented domain structures.
Such a finding is highly surprising, given the very
close similarity of chimpanzees and humans. The overall
nucleotide identity between the two genomes is around
95%, with much of the difference found in the form of
small insertions in one genome relative to the other [2].
Indeed, humans have been nicknamed “The Third
Chimpanzee” [3].
A re-analysis of the results of Anamika et al shows
that several of their reported novel structures are
entirely known. Furthermore, their results consistently
invest in the chimp gene models a degree of confidence
which they do not warrant, given that there is very little
EST data for chimps and so most models are de novo
predictions. In many cases, sequence data available prior
to the submission of the Anamika et al paper supplies
alternate, more conservative interpretations of chimp
gene structure. Two examples are examined in depth
below, but this excessive interpretation of questionable
gene models pervades the Anamika et al work.
Results & Discussion
In one case, Anamika et al claim to identify a chimp
kinase (ENSPTRP00000001150) whose closest kinase
domain relative in human has 31% identity, a distance
which is nearly unimaginable given the great similarity
between chimps and humans. Furthermore, this particu-
lar kinase is claimed to have greatest similarity to casein
kinase 1 but possesses a polo box, a domain involved in
the specific recognition of phosphorylated peptides. Polo
boxes have been found only in polo-like kinases [4], and
s ot of i n dap o l ob o xo nak i n a s ei nad i f f e r e n ts u b f a m -
ily (such as casein kinase 1) would be a very remarkable
finding. However, a BLAST search of the chimp ORF
against the RefSeq human protein database reveals the
best human match to be Polo-like kinase 3 (PLK3), with
>90% sequence identity overall (Figure 1) and 100%
identity. Furthermore, careful searching of the chimpan-
zee whole-genome shotgun sequence reveals reads con-
sistent with most of the pieces missing relative to * Correspondence: keith.e.robison@gmail.com
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tion of exon 3. Supplementation with this additional
data yields a chimp gene model with 100% identity in
the protein kinase domain (positions 62 to 314 as anno-
tated in UniProt). The restored sequence also contains
the ATP-binding site, as annotated in UniProt (positions
68-76); hence the chimp gene model used by Anamika
et al is either incomplete or non-functional as a kinase
due to the essentiality of this site to protein kinase func-
tion. While it cannot be conclusively demonstrated that
these should be incorporated into the chimp gene
model, their presence in the raw sequence data suggests
that a finished assembly would probably contain the
missing exonic regions. It is also worth noting that the
missing pieces each correspond to one or more contigu-
ous exons; in other words the differences between the
chimp model and the human protein are entirely
explainable by the gene prediction program skipping
exons. One interesting possibility raised by these chimp
fragments is that chimp PLK3 has deleted a short region
of exon 3. This is supported by two reads in the NCBI
Trace Archive. However, given the sparseness of data it
could also be the case that the remainder of exon 3 is
present in the chimp genome but as yet unsequenced or
that both of these reads contain artifacts preventing the
detection of the missing portion. Furthermore, the
chimp protein contains an insertion (GGDLPSVEEVE-
PAPP) relative to both human and macaque proteins.
Otherwise, it is striking that the potential chimp exons
have precisely the same amino acid boundaries as the
known human gene structure. In any case, the simplest
conclusion is that ENSPTRP00000001150 is chimp
PLK3 and its possession of a polo-box therefore
unsurprising.
The treatment of ENSPTRP00000001150 exemplifies
several analytic practices in the Anamika paper which
lend themselves to error. First, the paper’sm e t h o d o l o g y
uses Ensembl as the source of the human proteins.
Ensembl is a powerful genomic analytic tool, but it relies
on automated protein predictions and the proteins lack
authoritative assignment to genes. The RefSeq protein
database would have been a far superior reference data-
base (as implied by the name!). Comparing against the
full non-redundant protein database is also a useful
approach to test conclusions made using the highly
annotated, but incomplete, RefSeq database. The tree
purporting to show the relationship of
ENSPTRP00000001150 to casein kinases should have
served as a warning flag as well, for the chimp kinase
cannot be ruled out as an outgroup in this figure.
Ensuring the rooting of the casein kinase subfamily by
including representative members of other kinase subfa-
milies might have flagged this error. Even better, a
paper reporting a pairwise comparison of one proteome
subset with another would be well served to present
that entire alignment score matrix as a supplementary
table. A paper such as this should also include all of the
protein kinase sequences used as a supplementary file so
that its conclusions can be rapidly validated by reviewers
and interested readers.
The chimp protein ENSPTRP00000000076 is claimed
as a “chimpanzee specific multi-domain architecture”
containing a PB1 domain followed by a protein kinase
C-like domain. This particular pairing is then claimed to
have been found only in a single sea squirt kinase. Re-
alignment to RefSeq reveals that the domain architec-
ture was correctly describedh e r e .H o w e v e r ,t h i sk i n a s e
is clearly the chimp ortholog of human PKC zeta with
87% identity (Figure 2). Long before the chimpanzee
genome was sequenced, two different groups described
this architecture in human PKC and demonstrated the
formation of dimers via the PB1 domain [5,6].
ENSPTRP00000000076 is also claimed to lack a diacyl-
glycerol (DAG) binding domain, but three chimpanzee
ESTs deposited in October 2007 (DC524857, DC519886
and CD524857) are consistent with the presence of the
DAG-binding domain in chimpanzee PKC-zeta (Figure
2). The dropped region corresponds precisely to the
sixth exon of human PKC-zeta isoform 1.
These flaws are repeated in several of their other
examples of “novel” chimpanzee architectures where the
chimp sequence contains insertions or deletions relative
to human. In no case does the evidence for the novel
chimp architecture go beyond a de novo gene prediction
purely from genomic DNA. Such prediction is well-
recognized as a difficult and error-prone challenge, and
in the absence of more direct evidence (such as EST
support) such predictions cannot be trusted. One recent
paper did identify numerous indels between chimp and
h u m a nu s i n gt h es a m es o r to fs e q u e n c ed a t a[ 7 ] .H o w -
ever this paper verified these changes via experimental
PCR evidence; such validation is lacking in the Anamika
paper.
Presenting bioinformatics results in a manner which is
accessible both to experts in the field can be challen-
ging. In particular, the appropriate way to identify
sequences presents tradeoffs: unique accession numbers
eliminate ambiguity for computational biologists, but
make it impossible for a biologist to quickly assess the
biological plausibility or implications of a result. The
Anamika et al paper illustrates the critical importance of
presenting results in a biologically legible manner, so
that surprising findings can be quickly cross-checked.
This is particularly relevant in the kinase field, where
the elegant kinase tree of Manning et [8] has become
iconic and appears on posters, apparel and as a basis for
figures in other papers (e.g. Karaman et al [9]). As noted
above, with the inclusion of proper supplementary files
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Page 2 of 8Figure 1 Alignment of ENSPTRP00000001150 with PLK3 from human (RefSeq NP_004064.2), exon structure from human, and chimp
Whole Genome Shotgun reads from the NCBI trace archive corresponding to segments homologous to human PLK3 but missing
from ENSPTRP00000001150. Asterisks mark remaining amino acid changes between human and chimp PLK3 if all of the additional
information is incorporated. Exons implied by chimp whole genome shotgun traces (NCBI Trace Archive entries 231320434, 240048640 and
236037896) are also shown. The kinase domain of human PLK3 is highlighted in yellow, with the key ATP binding region underlined.
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sions, the risk of ambiguity is eliminated.
One final recommendation is made for the design of
such computational analyses. As useful as a correctly
executed pairwise comparison to human could be, even
more valuable would be a three-way comparison with
mouse. The mouse genome has been finished to a simi-
lar quality standard as the human genome, and an in
depth analysis of its protein kinases has been published
[10]. Such a third reference would be useful for putting
any unusual architectures into context, and would also
greatly reduced the risks of mis-identifying chimp PLK3
as a casein kinase.
Concluding remarks
None of the domain architectures proposed by Anamika
et al appear to be both novel and well-supported; the
few that are well supported have been previously
Figure 2 Alignment of ENSPTRP00000000076, human PKC-zeta isoform 1 (RefSeq NP_002735.3) and chimp ESTs containing sequences
homologous to human PKC-zeta but missing from ENSPTRP00000000076. The lowercase ‘a’ for DC519886 requires the insertion of 1
nucleotide to maintain frame. Asterisks mark remaining amino acid changes between human and chimp PLK3 if all of the additional information
is incorporated.
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architectures lack any experimental support and are
therefore likely to be the artifacts of de novo gene pre-
diction on a draft quality genome. In many cases, bring-
ing in additional evidence in the form of chimp ESTs or
individual WGS reads undermines the architectures ana-
lyzed by Anamika et al. These sequences appear to have
been available at the time of their analysis and therefore
could have been consulted as part of the totality of evi-
dence for (or against) the gene structures of chimpanzee
protein kinases. More careful choices of reference pro-
teomes would likely have prevented many of the misi-
dentifications, and more careful attention to the quality
of the evidence for the conclusions drawn would have
led to them being carefully hedged, if made at all.
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The article by Robison [11] discusses an important
point on the validity of gene prediction for the presently
available genome assembly of chimpanzee genome. The
entire discussion is unfortunately misplaced in the con-
text of analysis of domain combinations in protein
kinases encoded in the chimpanzee genome that was
reported by Anamika et al [12]. In general, roots of such
problems stem not only from the quality of gene predic-
tion but also from the quality of the genomic data and
assembly. Though the discussion is misplaced within a
highly specific context of domain combinations in chim-
panzee kinases it is certainly important to discuss and
understand the quality of genomic assembly of chimpan-
z e ea n dt h eq u a l i t yo fg e n ep r e d i c t i o n sa st h e yc o u l d
have significant impact on the results of any analysis on
chimpanzee proteome.
Anamika et al [12] have used the ENSEMBL database
(release 46) in their comparative analysis of human and
chimpanzee kinases. In our opinion, ENSEMBL has set
quite high standards on the quality of datasets dissemi-
nated including gene annotation [13]. High quality of
the datasets is achieved in ENSEMBL in a series of
stages. Of particular relevance to the comparison of
human and chimpanzee proteomes, we would like to
draw the attention to the steps employed by ENSEMBL:
In the first stage of the gene build species-specific pro-
teins are aligned to the genome and a transcript struc-
ture is built for the protein on the genome. It must be
n o t e dt h a tt h i ss t e pi sf o l l o w e db yt h es i m i l a r i t ys t a g e ,
in which proteins from closely related species are used
to build transcript structure in regions were a targeted
transcript structure is absent. For those species having
significant number of experimentally identified protein
sequences, this stage has a major impact on the gene
structures in the genebuild. However, according to the
documentation of ENSEMBL, for species with fewer
species-specific protein sequences, this stage plays an
even more important role in predicting gene structures.
It should also be noted that the next stage in ENSEMBL
involves alignment of species-specific cDNA and EST
sequences to the genome and a careful treatment of
non-translated region of cDNA. The final set of predic-
tion corresponds to multi-transcript genes as it is
derived by combining identical transcripts correspond-
ing to different protein sequences. For every transcript
model, the protein and mRNA sequences serve as sup-
portive evidence.
Based on these steps taken in ENSEMBL, it is clear
that automatically annotated genes too have strong
mRNA and cDNA evidence from other species. Thus it
is difficult to accept that there are serious problems
with many of the genes predicted and listed in
ENSEMBL database.
Robison points out differences between ENSEMBL
and RefSeq databases in terms of annotation and gene
prediction. While this matter is certainly beyond the
analysis of domain combinations in kinases, it is more a
comparison of quality of two different databases which
are of high quality in their own right. As stated by Ana-
mika et al in their paper [12], the human proteome data
used in their analysis is based on the NCBI 36 assembly
of the human genome, released in November 2005. It is
composed of 43,570 protein sequences: 3,614 “novel
peptides”, 18,642 “known peptides” and 21,314 “known-
ccds peptides”. The annotation “known-ccds” suggests
that these sequences are part of a core set consistently
annotated, high quality data in the frame of the Consen-
sus Coding Sequence (CCDS) project. The phrase
“known peptides” suggests that these proteins were
mapped to entries in Swiss-Prot, RefSeq or SPTrEMBL
during the annotation process. Given the high propor-
tion of proteins that are flagged as “known-ccds” or
“known peptides”,w ea r eo ft h ei m p r e s s i o nt h a tt h e
quality of the data used by Anamika et al is generally
very good.
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quality, we agree with Robison that, in general, quality
of the genome sequence and assembly as well as quality
of gene prediction can suggest dubious dissimilarities
between chimpanzee and human proteins. However,
based on our more detailed comparative analysis of
entire proteomes of human and chimpanzee there are
genuine significant differences between proteins of
human and chimpanzee that can not be easily explained
on the basis of genome sequence quality and gene pre-
diction. For example, we consider the cases discussed by
Robison in the later sections of this article.
Unfortunately there are a few points of comprehen-
sion, different from what Anamika et al intended,
expressed in Robison article. For example, Robison
states: “......they (Anamika et al) concluded that chimps
possess many kinases with unprecedented domain struc-
tures”. It should be noted that Anamika et al report 587
putative protein kinases in chimp and they report only 3
cases of chimp-specific architectures, displayed in Figure
three a and discussed in the text. We believe that Robi-
son’s contention of 3 out of 587 (0.5%) as “many” is
inappropriate. On the contrary 584 chimp kinases do
not exhibit any difference in terms of domain structure
compared to human kinases.
In another case Robison seems to have understood
that Anamika et al claim to identify a chimp kinase
(ENSPTRP00000001150) whose closest relative in
human has 31% identity. Anamika et al did not imply
such a point. Anamika et al did not state that when
searching for orthologues of ENSPTRP00000001150 in
the human proteome, the closest human sequence is
found to have 31% sequence identity. Indeed in Table
two of the Anamika et al paper, the closest human
orthologue of ENSPTRP00000001150 is listed as
ENSP00000361275 which is described as PLK3_HU-
MAN shown on Figure one in Robison paper. The dif-
ference between sequence identity reported by Robison
(>90%) and us (65.5%) comes from the formula used to
compute the percentage: with respect to the length of
the sequence or the length of the alignment. Thus, in
this example the apparent contradiction stems from dif-
ference in understanding. Indeed, both Anamika et al
and Robison concur on the matter of nearest human
protein of ENSPTRP00000001150.
R o b i s o np r o v i d e sa ni m p r e s s i o nt h a tA n a m i k ae ta l
considers this kinase as a casein kinase 1 with a polo
box. Again, Anamika et al did not mean to give such an
impression. On the contrary Anamika et al state in page
3 of their paper that the catalytic domain of the
sequence ENSPTRP00000001150 was classified as casein
kinase 1 subfamily because it has 31% identity and e-
value equal to 2 × 10
-16 with the Position Specific Scor-
ing Matrix (PSSM) of catalytic domain of casein kinase
1 in the Reverse BLAST analysis. In no way it means
that the closest relative in human is 31% identical. How-
ever the point made by Anamika et al, but, seemed to
have missed by Robison is that the amino acid sequence
pattern of the catalytic region of ENSPTRP00000001150
is similar to casein kinase 1 PSSM. As stated in our
paper, we have used multiple PSSMs created for the 55
protein kinase subfamilies represented in Hanks and
Hunter classification scheme [13] as query to search
against the chimpanzee proteome using RPS-BLAST.
The kinase domain of ENSPTRP00000001150 has
shown to have highest similarity with a PSSM represen-
tative of the casein kinase 1 subfamily. So, this is an
interesting case of kinase catalytic region more similar
to casein kinase 1 while the full length protein sequence
is more similar to that of a POLO kinase due to the
occurrence of a POLO box in ENSPTRP00000001150.
So, we contend that this is a difficult case of classifica-
tion purely from sequence analysis. It will be interesting
to understand the role of ENSPTRP00000001150 in sig-
naling process from experimental studies when they
become available.
Robison provides an interesting analysis of whole-gen-
ome shotgun sequence comparing the genomic regions
of ENSPTRP00000001150 and ENSP00000361275 and
speculates that the finished product will probably con-
tain currently missing exonic regions. We concur with
this speculation. This is a good possibility to look for
when genomic data with better accuracy becomes avail-
able. However currently it remains speculative. Robison
identified the ATP-binding site in human
ENSP00000361275/PLK3_HUMAN, which is missing in
the chimp sequence. Robison thus concludes that this
chimp protein is either incomplete or non-functional.
We agree that the corresponding protein, if complete
and shown to lack ATP binding site, might be non-
functional as a kinase. It should be emphasized that
Anamika et al discussed this example as chimp protein
kinases with interesting difference compared to their
closest human homologue.
Anamika et al reported that the example of the chimp
kinase ENSPTRP00000000076 contains a PB1 domain
followed by a protein kinase C-like domain and they
further reported that this domain architecture is seen
only in a sea squirt kinase. Although Anamika et al used
Pfam database version 22.0, the architecture PB1/cataly-
tic domain/PKC terminal domain is actually reported
only in a single sea squirt kinase in Pfam version 23.0.
Kinases discussed in references 5 and 6 of Robison
paper possess a DAG binding domain between PB1 and
catalytic domains. Anamika et al also identified these
cases in their analysis. In page 7 of the Anamika et al
paper it is stated that “Our analysis identified two chim-
panzee PKCs and a human PKC with a similar
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binding domain is inserted between the PB1 and the
protein kinase domain.” The Robison article reports that
three chimpanzee ESTs deposited in October 2007
(DC524857, DC519886 and CD524857) are consistent
with the presence of the DAG-binding domain in chim-
panzee PKC-zeta. In this context it should be pointed
out that Anamika et al report has identified the PB1/
DAG binding/catalytic domain/PKC terminal domain
architecture in two chimp kinases. Indeed in Table two
of Anamika et al the authors have already mentioned
ENSP00000367830 (human PKCzeta) as 87% identical to
the chimp kinase ENSPTRP00000000076 that was also
mentioned by Robison as the point missed by Anamika
et al. Robison provides an interesting analysis of
ENSPTRP00000000076 and human PKC-zeta with exo-
nic structure, showing that the deletion in
ENSPTRP00000000076 corresponds precisely to the
sixth exon of human PKC-zeta isoform 1, and concludes
that sequence of ENSPTRP00000000076 is incomplete.
This remains to be confirmed when better genomic data
becomes available.
So, we disagree with the statement made by Robison
that none of the domain architectures proposed by Ana-
mika et al appear to be both novel and well-supported.
Indeed many of the points raised by Robison seem to
stem from misunderstanding of the statements made by
Anamika et al. We agree with Robison who suggests
that a list of all the kinase sequences analyzed should be
made available publicly. Indeed all the sequences used
in the Anamika et al analysis are publicly available in
the KinG web site http://hodgkin.mbu.iisc.ernet.in/~king
as mentioned in their paper.
In the context of discussion on how similar a human
protein sequence could be to the nearest homologue in
chimpanzee Robison appropriately recalls very high
nucleotide sequence identity between the two genomes.
We agree with this point. However, it has also been
p o i n t e do u tb yt h eC h i m p a n z e eG e n o m eS e q u e n c i n g
and Analysis Consortium [14] while comparing chim-
panzee and human genomic data that “Insertion and
deletion (indel) events are fewer in number than single-
nucleotide substitutions, but result in ~1.5% of the
euchromatic sequence in each species being lineage-spe-
cific”. Also, it is not clear if the possibilities of recombi-
nation/horizontal gene transfer/insertion-deletion/
frameshift events in either of the genomes can be
precluded.
Finally, chimpanzee proteome has been generated
from an automatic annotation system based on biologi-
cal evidences [14]. The human genome data, which is of
relatively high quality, was used as a guide for annota-
tion, by projecting the human gene models onto the
chimpanzee genome. Further, ENSEMBL carefully deter-
mines transcript on a case-by-case basis
(see http://www.ensembl.org/info/docs/genebuild/gen-
ome_annotation.html) [15]. It should be noted that all
ENSEMBL transcripts are also based on experimental
evidence from EMBL, UniProtKB, and RefSeq. Clearly,
one cannot do better than the data one is working with.
We contend that, in general, chimpanzee proteome
dataset in ENSEMBL is of good quality and not all the
differences one notes between human and chimpanzee
proteins can be explained solely on the basis of quality
of gene prediction. It is premature to conclude so at this
stage. While Anamika et al focused only on differences
in domain combinations of human and chimpanzee
kinases, even more significantly, a recent analysis [16]
identified a few completely unique genes in human
compared to chimpanzee by a very careful analysis
which provides useful guidelines on analysis of chimpan-
zee genomic data. Also, as pointed out by Robison, the
work of Volfovsky et al [17] reports numerous indels,
which are experimentally validated, in the sequence data
of chimp and human. Work of Knowles and McLysaght
[16] and Volfovsky et al [17] suggests that more con-
crete conclusions can only be arrived at when such
experimental validation has been achieved in a much
larger scale.
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